Recent News

• 25 April 2025   Press Release

  Korean Chemical Society and Enamine Partner to Advance Chemical Research

  Korean Chemical Society (KCS), an academic organization that promotes research and education in the field of chemistry and the chemistry profession, and Enamine, the leading provider of chemical compounds and drug discovery services, have signed a Memorandum of Understanding (MOU) to collaborate in the field of chemical science. The document outlines a shared framework for cooperation across academic and business domains. The aim of the MOU is to strengthen research and scientific exchange between the two organizations to drive progress in chemical science.

• 09 April 2025   Press Release

  Recursion and Enamine Release New AI-Enabled Targeted Compound Libraries

  Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the generation of screening libraries leveraging tools within its AI/ML platform, the Recursion OS, with Enamine's REAL Space, the world’s largest source of make-on-demand small molecules. Together, the two companies have curated 10 enriched screening libraries from over 15,000 newly synthesized compounds designed to accelerate drug discovery against the hundred most difficult to address biological areas and clinically relevant key drug targets.

• 02 April 2025   Press Release

  Enamine and ChemPass Collaborate to Accelerate Hit Discovery

  Enamine, the leading provider of chemical compounds and drug discovery services, and ChemPass, a contract research organization for computational and AI-assisted software, today announced their start of strategic partnership to provide hit discovery solutions to their customers.